Immunity to vaccine-preventable diseases among paediatric healthcare workers in Denmark, 2019

Background Healthcare workers (HCW) have been identified as index cases in disease outbreaks of vaccine-preventable diseases (VPD) in hospitals. Aim We investigated whether Danish paediatric HCW were protected against selected serious VPD. Methods We included 90% of staff members from two paediatric departments. All 555 HCW (496 women) supplied a blood sample for serology and filled in a questionnaire. Antibodies were measured with enzyme immunoassay against measles, mumps, rubella (MMR), varicella zoster, pertussis toxin and diphtheria toxin. Results Protective levels of IgG were found for measles (90.3%), mumps (86.5%), rubella (92.3%), varicella (98.6%) and diphtheria (80.5%). We found seropositivity for all three MMR components in 421 (75.9%) HCW, lowest in those younger than 36 years (63.3%). Only 28 (5%) HCW had measurable IgG to pertussis. HCW with self-reported immunity defined as previous infection or vaccination, had protective levels of IgG against measles, mumps, rubella and varicella in 87.4–98.8% of cases, not significantly higher than in those not reporting immunity. Previous history of disease had a high positive predictive value (PPV) of 96.8–98.8%. The PPV for previous vaccination ranged from 82.5% to 90.3%. In contrast, negative predictive values of self-reported history of disease and vaccination were remarkably low for all diseases. Conclusion The immunity gaps found primarily in young HCW indicate a need for a screening and vaccination strategy for this group. Considering the poor correlation between self-reported immunity and seropositivity, efforts should be made to check HCW’s immune status in order to identify those who would benefit from vaccination.

[1]  A. Poulsen,et al.  Self-reported immunity and opinions on vaccination of hospital personnel among paediatric healthcare workers in Denmark , 2020, Vaccine.

[2]  M. Theodoridou,et al.  Vaccination of healthcare personnel in Europe: Update to current policies. , 2019, Vaccine.

[3]  A. Pietroiusti,et al.  Cost-effectiveness of workplace vaccination against measles , 2019, Human vaccines & immunotherapeutics.

[4]  T. Bergström,et al.  Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections , 2019, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  A. Mankertz,et al.  Hospital outbreak of measles - Evaluation and costs of 10 occupational cases among healthcare worker in Germany, February to March 2017. , 2019, Vaccine.

[6]  M. Hernández-Guedea,et al.  Mumps outbreak with high complication rates among residents in a university teaching hospital. , 2019, American Journal of Infection Control.

[7]  K. Borgen,et al.  Large outbreak of mumps virus genotype G among vaccinated students in Norway, 2015 to 2016 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  R. Sá Machado,et al.  Measles outbreak in a tertiary level hospital, Porto, Portugal, 2018: challenges in the post-elimination era. , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[9]  H. Quinn,et al.  Declining measles antibodies in the era of elimination: Australia's experience. , 2018, Vaccine.

[10]  B. Webber,et al.  Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection. , 2017, Vaccine.

[11]  S. Blomqvist,et al.  Immunity against vaccine-preventable diseases in Finnish pediatric healthcare workers in 2015. , 2017, Vaccine.

[12]  R. V. Van BInnendijk,et al.  Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014. , 2016, The Journal of infectious diseases.

[13]  N. Hanson,et al.  Resurgence of Vaccine-Preventable Diseases in the United States: Anesthetic and Critical Care Implications , 2016, Anesthesia and analgesia.

[14]  K. Leder,et al.  Seroprotection to vaccine‐preventable diseases among workers at a Victorian tertiary hospital , 2016, Australian and New Zealand journal of public health.

[15]  M. Koopmans,et al.  Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  T. Fischer,et al.  Mumps resurgence in Denmark. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[17]  M. Hirose,et al.  Self-reported histories of disease and vaccination against measles, mumps, rubella and varicella in health care personnel in Japan. , 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[18]  M. Theodoridou,et al.  Nosocomial pertussis in neonatal units. , 2013, The Journal of hospital infection.

[19]  N. Nishimura,et al.  Seroprevalence survey on measles, mumps, rubella and varicella antibodies in healthcare workers in Japan: sex, age, occupational-related differences and vaccine efficacy , 2013, Epidemiology and Infection.

[20]  M. Paunio,et al.  Waning antibody levels and avidity: implications for MMR vaccine-induced protection. , 2012, The Journal of infectious diseases.

[21]  A. Nardone,et al.  Seroepidemiology of mumps in Europe (1996–2008): why do outbreaks occur in highly vaccinated populations? , 2012, Epidemiology and Infection.

[22]  J. Cherry Why Do Pertussis Vaccines Fail? , 2012, Pediatrics.

[23]  E. Alp,et al.  Prevaccination screening of health-care workers for immunity to measles, rubella, mumps, and varicella in a developing country: What do we save? , 2012, Journal of infection and public health.

[24]  Y. Bayram,et al.  Report on Experiments and Clinical Cases ― Susceptibility to Measles , Rubella , Mumps , and Varicella-zoster Viruses among Healthcare Workers , 2012 .

[25]  L. Grohskopf,et al.  Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2011, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[26]  G. Berbers,et al.  What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[27]  A. Nardone,et al.  European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus. , 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[28]  J. Langley,et al.  Variation in risk for nosocomial chickenpox after inadvertent exposure. , 2000, The Journal of hospital infection.

[29]  J. Remington,et al.  Cell-mediated immunity and its role in resistance to infection. , 1977, The Western journal of medicine.